Molecule Details
| InChIKey | QVQWCYWOMABSFT-MPQUPPDSSA-N |
|---|---|
| Compound Name | (18S,21R)-21-(benzylsulfonylamino)-N-[(4-carbamimidoylphenyl)methyl]-3,10,20-trioxo-2,5,8,11,19-pentazatetracyclo[21.2.2.25,8.112,16]triaconta-1(26),12,14,16(28),23(27),24-hexaene-18-carboxamide |
| Canonical SMILES | N=C(N)c1ccc(CNC(=O)[C@@H]2Cc3cccc(c3)NC(=O)CN3CCN(CC3)CC(=O)Nc3ccc(cc3)C[C@@H](NS(=O)(=O)Cc3ccccc3)C(=O)N2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.74 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile